DODC

DODC
Identifiers
	IUPAC name 1-(2,5-dimethoxy-3,4-dichlorophenyl)propan-2-amine;
CAS Number	1373918-65-0;
PubChem CID	168429515;
UNII	JW779U7A4H;
Chemical and physical data
Formula	C11H15Cl2NO2
Molar mass	264.15 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Clc1c(OC)cc(CC(C)N)c(OC)c1Cl;

DODC is a psychedelic drug from the substituted amphetamine family which acts as an agonist of the 5-HT_2A receptor. It is the 3,4-dichloro derivative of the well known psychedelic drug 2,5-Dimethoxy-4-chloroamphetamine (DOC). DODC was first officially published in a patent filed by Gilgamesh Pharmaceuticals in 2020,^[1] though anecdotal reports suggest it had been synthesised by clandestine chemists and its activity established several years prior to this.

References

^ WO 2022/006186, Kruegel AC, "Phenalkylamines and Methods of Treating Mood Disorders.", published January 2022, assigned to Gilgamesh Pharmaceuticals.

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

[1] WO 2022/006186, Kruegel AC, "Phenalkylamines and Methods of Treating Mood Disorders.", published January 2022, assigned to Gilgamesh Pharmaceuticals.

[1]

Identifiers

IUPAC name 1-(2,5-dimethoxy-3,4-dichlorophenyl)propan-2-amine
CAS Number	1373918-65-0
PubChem CID	168429515
UNII	JW779U7A4H
Chemical and physical data
Formula	C₁₁H₁₅Cl₂NO₂
Molar mass	264.15 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES Clc1c(OC)cc(CC(C)N)c(OC)c1Cl

DODC

See also

References